Skip to main content
. 2017 Mar 7;17:38. doi: 10.1186/s12935-017-0404-z

Fig. 3.

Fig. 3

Anticancer activity of HLBT-100 on the NCI60 cancer cell line panel. The compound was first screened at a single concentration of 100 µM and having satisfied the NCI predetermined threshold (data not shown), the molecule was subjected 5-dose response screen